Allogene Therapeutics, Inc.ALLONASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-20.84%
↓ 603% below average
Average (7y)
4.14%
Historical baseline
Range
High:33.52%
Low:-20.84%
Volatility
1312.1%
High variability
| Period | Value |
|---|---|
| 2024 | -20.84% |
| 2023 | -5.25% |
| 2022 | 16.45% |
| 2021 | 14.09% |
| 2020 | 33.52% |
| 2019 | -4.82% |
| 2018 | 0.00% |
| 2017 | 0.00% |